Elliot Wakeam, MD, MPH, Meredith Giuliani, MBBS, MEd, Natasha B

Slides:

Advertisements

Similar presentations

Elizabeth A. David, MD, David T

Advertisements

Jeffrey L. Port, MD, Robert J. Korst, MD, Paul C. Lee, MD, Amanda L

Complete Thoracic Mediastinal Lymphadenectomy Leads to a Higher Rate of Pathologically Proven N2 Disease in Patients With Non-Small Cell Lung Cancer

Thomas J. Birdas, MD, Richard P. M

Outcomes of Sublobar Resection Versus Lobectomy for Stage I Non–Small Cell Lung Cancer: A 13-Year Analysis Amgad El-Sherif, MD, William E. Gooding, MS,

Melanie Subramanian, MD, Timothy McMurry, PhD, Bryan F

Chun Chieh Lin, PhD, MBA, Matthew P

Missed Intrapulmonary Lymph Node Metastasis and Survival After Resection of Non- Small Cell Lung Cancer Matthew P. Smeltzer, PhD, Nicholas Faris, MDiv,

Joshua E. Rosen, BASc, Hari B

Zhiqiang Xue, MD, Fengying Wu, MD, Karlyn E

Phillips B. Harrington, MD, William W. McAlexander, MD, Ayesha S

Invasive Mediastinal Staging Guideline Concordance

Chi-Fu Jeffrey Yang, MD, Derek Y. Chan, BSE, Paul J

Nirav S. Kapadia, MD, MS, Luca F. Valle, MD, Julie A

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD

Adjuvant Chemotherapy with 5-Fluorouracil and Cisplatin in Lymph Node-Positive Thoracic Esophageal Squamous Cell Carcinoma Jeeyun Lee, MD, Kyoung-Eun.

Log Odds of Positive Lymph Nodes Predicts Survival in Patients After Resection for Esophageal Cancer Jinlin Cao, MD, Ping Yuan, MD, Honghai Ma, MD, Peng.

Long-Term Outcome After Resection of Non-Small Cell Lung Cancer Invading the Thoracic Inlet Stéphane Collaud, MD, MS, Tiago Machuca, MD, PhD, Olaf Mercier,

Robert E. Merritt, MD, Richard I. Whyte, MD, Nicole T

Video-Assisted Thoracic Surgery Lobectomy: Experience With 1,100 Cases

Castigliano M. Bhamidipati, DO, MS, George J

David T. Cooke, MD, Danh V. Nguyen, PhD, Ying Yang, MS, Steven L

Lymph Node Evaluation Achieved by Open Lobectomy Compared With Thoracoscopic Lobectomy for N0 Lung Cancer Robert E. Merritt, MD, Chuong D. Hoang, MD,

Lucas W. Thornblade, MD, MPH, Michael S

Trimodal Therapy for Histologically Proven N2/3 Non–Small Cell Lung Cancer: Mid-Term Results and Indicators for Survival Volker Steger, MD, Thorsten.

Quality Indicators for Non-Small Cell Lung Cancer Operations With Use of a Modified Delphi Consensus Process Gail Darling, MD, Richard Malthaner, MD,

Varun Puri, MD, Andrew Tran, MS, Jennifer M. Bell, BS, Traves D

Survival of Patients With or Without Symptoms Undergoing Potentially Curative Resections for Primary Lung Cancer Andrea R.G. Sheel, BS (Hons), MBChB,

Pulmonary Resection in the Treatment of Multidrug-Resistant Tuberculosis: A Retrospective Study of 56 Cases Haifeng Wang, MM, Hongsheng Lin, MM, Gening.

Chordae Replacement Versus Resection for Repair of Isolated Posterior Mitral Leaflet Prolapse: À Ègalité Joerg Seeburger, MD, Volkmar Falk, MD, PhD,

Asad A. Shah, MD, Mathias Worni, MD, MHS, Christopher R

Thomas J. Birdas, MD, Richard P. M

Quality Measures in Clinical Stage I Non-Small Cell Lung Cancer: Improved Performance Is Associated With Improved Survival Pamela Samson, MD, MPHS, Traves.

Utility of Routine PET Imaging to Predict Response and Survival After Induction Therapy for Non-Small Cell Lung Cancer Stephen A. Barnett, MBBS, Robert.

Age-Dependent Gender Disparities in Post Lung Transplant Survival Among Patients With Idiopathic Pulmonary Fibrosis Shahid I. Sheikh, MD, Don Hayes,

Radical Lymph Node Dissection in Primary Esophagectomy for Esophageal Squamous Cell Carcinoma Chen-Sung Lin, MD, PhD, Chih-Tao Cheng, MD, DrPH, Chao-Yu.

Use of Amiodarone After Major Lung Resection

Elliot Wakeam, MD, MPH, James P. Byrne, MD, Gail E

Comparison of the 6th and 7th Editions of the American Joint Committee on Cancer Tumor-Node-Metastasis Staging System in Patients With Resected Esophageal.

Outcomes and Costs for Major Lung Resection in the United States: Which Patients Benefit Most From High-Volume Referral? Elliot Wakeam, MD, MPH, Joseph.

Number of Lymph Nodes Associated With Maximal Reduction of Long-Term Mortality Risk in Pathologic Node-Negative Non–Small Cell Lung Cancer Raymond U.

Recurrence and Survival After Segmentectomy in Patients With Prior Lung Resection for Early-Stage Non-Small Cell Lung Cancer Lisa M. Brown, MD, Brian.

Andrew P. Dhanasopon, MD, Michelle C. Salazar, MD, Jessica R

Felix G. Fernandez, MD, Onkar Khullar, MD, Seth D

Differences in Patterns of Recurrence in Early-Stage Versus Locally Advanced Non- Small Cell Lung Cancer Feiran Lou, MD, MS, Camelia S. Sima, MD, MS,

Kathryn E. Engelhardt, MD, Malcolm M. DeCamp, MD, Anthony D

Eric S. Weiss, MD, MPH, Jeremiah G. Allen, MD, Christian A

Sublobar Resection Provides an Equivalent Survival After Lobectomy in Elderly Patients With Early Lung Cancer Jiro Okami, MD, PhD, Yuri Ito, PhD, Masahiko.

Selective Mediastinal Lymphadenectomy for Clinico-Surgical Stage I Non–Small Cell Lung Cancer Morihito Okada, MD, PhD, Toshihiko Sakamoto, MD, PhD, Tsuyoshi.

Characteristics of Malignant Pleural Mesothelioma in Women

Asvin M. Ganapathi, MD, Paul J. Speicher, MD, Anthony W

Adhering to Quality Measures in Esophagectomy Is Associated With Improved Survival in All Stages of Esophageal Cancer Pamela Samson, MD, MPHS, Varun.

Stephen R. Broderick, MD, MPHS, Aalok P. Patel, BS, BA, Traves D

Is There a Benefit to Prolonging the Interval Between Neoadjuvant Chemoradiation and Esophagectomy in Esophageal Cancer? Anna Lee, MD, MPH, Andrew T.

Shared Decision Making and Effective Risk Communication in the High-Risk Patient With Operable Stage I Non-Small Cell Lung Cancer Pamela Samson, MD,

Prognostic Heterogeneity in Multilevel N2 Non-Small Cell Lung Cancer Patients: Importance of Lymphadenopathy and Occult Intrapulmonary Metastases Yukinori.

Effects of Delayed Surgical Resection on Short-Term and Long-Term Outcomes in Clinical Stage I Non-Small Cell Lung Cancer Pamela Samson, MD, Aalok Patel,

Neal S Goldstein, MD The Annals of Thoracic Surgery

Relevance of Lymph Node Micrometastases in Radically Resected Endobronchial Carcinoid Tumors Tommaso Claudio Mineo, MD, Gianluca Guggino, MD, Davide.

Immediate and Long-Term Survival After Surgery for Lung Cancer in Heart Transplant Recipients Patrick Bagan, MD, Jalal Assouad, MD, Pascal Berna, MD,

Effect of Formalin Fixation on Tumor Size Determination in Stage I Non-Small Cell Lung Cancer Po-Kuei Hsu, MD, Hsu-Chih Huang, MD, Chih-Cheng Hsieh,

Clinical Outcome After Pulmonary Resection for Lung Cancer Patients on Hemodialysis Toshiro Obuchi, MD, Wakako Hamanaka, MD, Yasuhiro Yoshida, MD, Jun.

Survival and Outcomes of Pulmonary Resection for Non-Small Cell Lung Cancer in the Elderly: A Nested Case-Control Study Robert J. Cerfolio, MD, Ayesha.

Surveillance Epidemiology and End Results Evaluation of the Role of Surgery for Stage I Small Cell Lung Cancer James B. Yu, MD, Roy H. Decker, MD, PhD,

Mark I. Block, MD The Annals of Thoracic Surgery

Lobectomy Versus Limited Resection in T1N0 Lung Cancer

Domenico Galetta, MD, PhD, Lorenzo Spaggiari, MD, PhD

Early Surgical Results After Pneumonectomy for Non-Small Cell Lung Cancer are not Affected by Preoperative Radiotherapy and Chemotherapy Tomas Gudbjartsson,

Thirty-Day Mortality Underestimates the Risk of Early Death After Major Resections for Thoracic Malignancies Robert R. McMillan, MD, MPH, Alexandra Berger,

Induction Chemoradiation Is Not Superior to Induction Chemotherapy Alone in Stage IIIA Lung Cancer Asad A. Shah, MD, Mark F. Berry, MD, Ching Tzao, MD,

Presentation transcript:

Indications for Adjuvant Mediastinal Radiotherapy in Surgically Resected Small Cell Lung Cancer Elliot Wakeam, MD, MPH, Meredith Giuliani, MBBS, MEd, Natasha B. Leighl, MD, MS, Samuel R.G. Finlayson, MD, MPH, Thomas K. Varghese, MD, MS, Gail E. Darling, MD The Annals of Thoracic Surgery Volume 103, Issue 5, Pages 1647-1653 (May 2017) DOI: 10.1016/j.athoracsur.2016.11.039 Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

The Annals of Thoracic Surgery 2017 103, 1647-1653DOI: (10. 1016/j The Annals of Thoracic Surgery 2017 103, 1647-1653DOI: (10.1016/j.athoracsur.2016.11.039) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 Kaplan-Meier survival curves stratified by pathologic nodal stage: (A) all patients (log-rank [LR] test p = 0.15); (B) pathologic N0 (LR test p = 0.41); (C) pathologic N1 (LR test p = 0.008); and (D) pathologic N2 (LR test p < 0.0001). (AMR = adjuvant mediastinal radiotherapy; CI = confidence interval.) The Annals of Thoracic Surgery 2017 103, 1647-1653DOI: (10.1016/j.athoracsur.2016.11.039) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

Fig 2 Subpopulation analysis. Kaplan-Meier survival curves, stratified by procedure, for node- and margin-negative patients: (A) lobectomy (log-rank test p = 0.25), and (B) sublobar resections (log-rank test p = 0.08). (AMR = adjuvant mediastinal radiotherapy; CI = confidence interval.) The Annals of Thoracic Surgery 2017 103, 1647-1653DOI: (10.1016/j.athoracsur.2016.11.039) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions